49 results on '"Baron, Todd"'
Search Results
2. The "Scope" of Post-ERCP Pancreatitis.
- Author
-
Parekh PJ, Majithia R, Sikka SK, and Baron TH
- Subjects
- Age Distribution, Chemoprevention methods, Cholangiopancreatography, Endoscopic Retrograde methods, Female, Humans, Male, Middle Aged, Pancreatitis prevention & control, Risk Factors, Sex Distribution, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatitis etiology
- Abstract
Pancreatitis is the most common adverse event of endoscopic retrograde cholangiopancreatography, with the potential for clinically significant morbidity and mortality. Several patient and procedural risk factors have been identified that increase the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP). Considerable research efforts have identified several pharmacologic and procedural interventions that can drastically affect the incidence of PEP. This review article addresses the underlying mechanisms at play for the development of PEP, identifying patient and procedural risk factors and meaningful use of risk-stratification information, and details current interventions aimed at reducing the risk of this complication., (Copyright © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
3. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial.
- Author
-
Elmunzer BJ, Serrano J, Chak A, Edmundowicz SA, Papachristou GI, Scheiman JM, Singh VK, Varadarajulu S, Vargo JJ, Willingham FF, Baron TH, Coté GA, Romagnuolo J, Wood-Williams A, Depue EK, Spitzer RL, Spino C, Foster LD, and Durkalski V
- Subjects
- Administration, Rectal, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Clinical Protocols, Combined Modality Therapy, Female, Humans, Indomethacin adverse effects, Male, Middle Aged, Pancreatitis diagnosis, Pancreatitis etiology, Research Design, Risk Assessment, Risk Factors, Time Factors, Tissue Banks, Treatment Outcome, United States, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Cholangiopancreatography, Endoscopic Retrograde instrumentation, Indomethacin administration & dosage, Pancreatitis prevention & control, Stents
- Abstract
Background: The combination of prophylactic pancreatic stent placement (PSP) - a temporary plastic stent placed in the pancreatic duct - and rectal non-steroidal anti-inflammatory drugs (NSAIDs) is recommended for preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in high-risk cases. Preliminary data, however, suggest that PSP may be unnecessary if rectal NSAIDs are administered. Given the costs and potential risks of PSP, we aim to determine whether rectal indomethacin obviates the need for pancreatic stent placement in patients undergoing high-risk ERCP., Methods/design: The SVI (Stent vs. Indomethacin) trial is a comparative effectiveness, multicenter, randomized, double-blind, non-inferiority study of rectal indomethacin alone versus the combination of rectal indomethacin and PSP for preventing PEP in high-risk cases. One thousand four hundred and thirty subjects undergoing high-risk ERCP, in whom PSP is planned solely for PEP prevention, will be randomized to indomethacin alone or combination therapy. Those who are aware of study group assignment, including the endoscopist, will not be involved in the post-procedure care of the patient for at least 48 hours. Subjects will be assessed for PEP and its severity by a panel of independent and blinded adjudicators. Indomethacin alone will be declared non-inferior to combination therapy if the two-sided 95 % upper confidence bound of the treatment difference is less than 5 % between the two groups. Biological specimens will be obtained from trial participants and centrally banked., Discussion: The SVI trial is designed to determine whether PSP remains necessary in the era of NSAIDs pharmacoprevention. The associated bio-repository will establish the groundwork for important scientific breakthrough., Trial Registration: NCT02476279, registered June 2015.
- Published
- 2016
- Full Text
- View/download PDF
4. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
- Author
-
Dumonceau JM, Andriulli A, Elmunzer BJ, Mariani A, Meister T, Deviere J, Marek T, Baron TH, Hassan C, Testoni PA, and Kapral C
- Subjects
- Administration, Rectal, Cholangiopancreatography, Endoscopic Retrograde methods, Hormones administration & dosage, Humans, Nitroglycerin administration & dosage, Preoperative Period, Risk Assessment, Somatostatin administration & dosage, Stents, Vasodilator Agents administration & dosage, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Diclofenac administration & dosage, Indomethacin administration & dosage, Pancreatitis etiology, Pancreatitis prevention & control
- Abstract
This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). It addresses the prophylaxis of post-endoscopic retrograde cholangiopancreatography (post-ERCP) pancreatitis. Main recommendations 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or indomethacin immediately before or after ERCP in all patients without contraindication. In addition to this, in the case of high risk for post-ERCP pancreatitis (PEP), the placement of a 5-Fr prophylactic pancreatic stent should be strongly considered. Sublingually administered glyceryl trinitrate or 250 µg somatostatin given in bolus injection might be considered as an option in high risk cases if nonsteroidal anti-inflammatory drugs (NSAIDs) are contraindicated and if prophylactic pancreatic stenting is not possible or successful. 2 ESGE recommends keeping the number of cannulation attempts as low as possible. 3 ESGE suggests restricting the use of a pancreatic guidewire as a backup technique for biliary cannulation to cases with repeated inadvertent cannulation of the pancreatic duct; if this method is used, deep biliary cannulation should be attempted using a guidewire rather than the contrast-assisted method and a prophylactic pancreatic stent should be placed. 4 ESGE suggests that needle-knife fistulotomy should be the preferred precut technique in patients with a bile duct dilated down to the papilla. Conventional precut and transpancreatic sphincterotomy present similar success and complication rates; if conventional precut is selected and pancreatic cannulation is easily obtained, ESGE suggests attempting to place a small-diameter (3-Fr or 5-Fr) pancreatic stent to guide the cut and leaving the pancreatic stent in place at the end of ERCP for a minimum of 12 - 24 hours. 4 ESGE does not recommend endoscopic papillary balloon dilation as an alternative to sphincterotomy in routine ERCP, but it may be advantageous in selected patients; if this technique is used, the duration of dilation should be longer than 1 minute., (© Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2014
- Full Text
- View/download PDF
5. Reply: To PMID 23376320.
- Author
-
Baron TH
- Subjects
- Humans, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Chemoprevention methods, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatic Ducts surgery, Pancreatitis prevention & control, Stents
- Published
- 2014
- Full Text
- View/download PDF
6. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
- Author
-
Law R, Leal C, Dayyeh BA, Leise MD, Balderramo D, Baron TH, and Cardenas A
- Subjects
- Acute Disease, Adult, Aged, Chi-Square Distribution, Female, Hospitals, High-Volume, Humans, Logistic Models, Male, Middle Aged, Minnesota, Multivariate Analysis, Odds Ratio, Pancreatitis diagnosis, Pancreatitis etiology, Retrospective Studies, Risk Factors, Spain, Time Factors, Adrenal Cortex Hormones therapeutic use, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Immunosuppressive Agents therapeutic use, Liver Transplantation adverse effects, Pancreatitis prevention & control, Prednisone therapeutic use
- Abstract
Endoscopic retrograde cholangiopancreatography (ERCP) is frequently used for diagnosis and therapeutic interventions in recipients of liver transplantation (LT) who develop biliary complications. Post-endoscopic retrograde cholangiopancreatography acute pancreatitis (PEP) is the most common major adverse event after ERCP; however, the frequency of PEP in LT recipients is not well established. We aimed to determine the rate of PEP in this population and to identify its predictors, especially among immunosuppressive agents. We reviewed all ERCP procedures performed in LT recipients after duct-to-duct biliary anastomoses at 2 high-volume transplant centers. Patients who had undergone sphincterotomy or had a surgically altered pancreaticobiliary anatomy before LT were excluded. Electronic medical records and endoscopy databases were used to obtain clinical, endoscopic, and medication data. A multivariate logistic regression analysis was used to determine predictors of PEP in this cohort. In all, 730 ERCP procedures were performed in 301 patients during the study period with an observed PEP rate of 3% (22/730). A univariate analysis revealed an increased risk of PEP with index ERCP after LT [odds ratio (OR) = 4.04, 95% confidence interval (CI) = 1.40-11.65] and in cases with difficult biliary cannulation (OR = 2.89, 95% CI = 1.10-7.65), whereas prednisone use was found to have a protective effect in both univariate (OR = 0.34, 95% CI = 0.14-0.84) and multivariate analyses (OR = 0.22, 95% CI = 0.09-0.57) after adjustments for difficult biliary cannulation and post-LT index ERCP. This retrospective analysis demonstrates that corticosteroid therapy has a protective role in the development of PEP in LT recipients. Further studies are warranted to confirm our findings., (© 2013 American Association for the Study of Liver Diseases.)
- Published
- 2013
- Full Text
- View/download PDF
7. ERCP.
- Author
-
Law R and Baron TH
- Subjects
- Catheter Ablation, Cholestasis etiology, Constriction, Pathologic etiology, Constriction, Pathologic surgery, Duodenal Diseases etiology, Duodenal Diseases surgery, Humans, Intestinal Perforation etiology, Intestinal Perforation surgery, Microscopy, Confocal, Neoplasms complications, Neoplasms surgery, Pancreatitis etiology, Bile Ducts pathology, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Cholangiopancreatography, Endoscopic Retrograde methods, Cholestasis surgery, Neoplasms pathology, Pancreatitis prevention & control, Stents
- Published
- 2013
- Full Text
- View/download PDF
8. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
- Author
-
Akbar A, Abu Dayyeh BK, Baron TH, Wang Z, Altayar O, and Murad MH
- Subjects
- Administration, Rectal, Humans, Treatment Outcome, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Chemoprevention methods, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatic Ducts surgery, Pancreatitis prevention & control, Stents
- Abstract
Background & Aims: Placement of pancreatic duct (PD) stents prevents pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). There is evidence that rectal administration of nonsteroidal anti-inflammatory drugs (NSAIDs) also prevents post-ERCP pancreatitis, but the 2 approaches alone have not been compared directly. We conducted a network meta-analysis to indirectly compare the efficacies of these procedures., Methods: PubMed and Embase were searched by 2 independent reviewers to identify full-length clinical studies, published in English, investigating use of PD stent placement and rectal NSAIDs to prevent post-ERCP pancreatitis. We identified 29 studies (22 of PD stents and 7 of NSAIDs). We used network meta-analysis to compare rates of post-ERCP pancreatitis among patients who received only rectal NSAIDs, only PD stents, or both., Results: Placement of PD stents and rectal administration of NSAIDs were each superior to placebo in preventing post-ERCP pancreatitis. The combination of rectal NSAIDs and stents was not superior to either approach alone. Pooled results showed that rectal NSAIDs alone were superior to PD stents alone in preventing post-ERCP pancreatitis (odds ratio, 0.48; 95% confidence interval, 0.26-0.87)., Conclusions: Based on a network meta-analysis, rectal NSAIDs alone are superior to PD stents alone in preventing post-ERCP pancreatitis, and should be considered first-line therapy for selected patients. However, these findings were limited by the small number of studies assessed (only 29 studies), potential publication bias, and the indirect nature of the comparison. High-quality, randomized, controlled trials are needed to compare these 2 interventions and confirm these findings., (Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
9. Severe ischemic pancreatitis following the use of extracorporeal membrane oxygenation.
- Author
-
Akbar A, Baron TH, and Freese DK
- Subjects
- Child, Humans, Male, Pneumonia, Viral therapy, Respiratory Insufficiency therapy, Extracorporeal Membrane Oxygenation adverse effects, Ischemia etiology, Pancreatitis etiology
- Published
- 2012
- Full Text
- View/download PDF
10. Placement of fully covered self-expandable metal stents to control entry-related bleeding during transmural drainage of pancreatic fluid collections (with video).
- Author
-
Akbar A, Reddy DN, and Baron TH
- Subjects
- Adult, Endoscopy, Digestive System, Humans, Male, Middle Aged, Necrosis complications, Necrosis surgery, Pancreatitis complications, Young Adult, Blood Loss, Surgical prevention & control, Drainage adverse effects, Hemostasis, Endoscopic methods, Pancreas pathology, Pancreatitis surgery, Stents
- Published
- 2012
- Full Text
- View/download PDF
11. Rectal indomethacin to prevent post-ERCP pancreatitis.
- Author
-
Baron TH, Abu Dayyeh BK, Abu Dayye BK, and Zinsmeister AR
- Subjects
- Female, Humans, Male, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Indomethacin therapeutic use, Pancreatitis prevention & control
- Published
- 2012
- Full Text
- View/download PDF
12. Letter in response to the recently published study: prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.
- Author
-
Chahal P and Baron TH
- Subjects
- Female, Humans, Male, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Foreign-Body Migration epidemiology, Pancreatitis epidemiology, Pancreatitis prevention & control, Stents classification
- Published
- 2012
- Full Text
- View/download PDF
13. Prevention of post-ERCP pancreatitis.
- Author
-
Saritaş Ü, Üstündağ Y, and Baron TH
- Subjects
- Cholangiopancreatography, Endoscopic Retrograde methods, Humans, Patient Selection, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatitis etiology, Pancreatitis prevention & control
- Published
- 2011
- Full Text
- View/download PDF
14. Biliary self-expandable metal stents and the risk of post-ERCP pancreatitis: the jury is still out.
- Author
-
Adler DG and Baron TH
- Subjects
- Humans, Incidence, Pancreatitis epidemiology, Prosthesis Design, Risk Factors, Treatment Failure, United States epidemiology, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatitis etiology, Stents adverse effects
- Published
- 2011
- Full Text
- View/download PDF
15. Making sense of meta-analyses on the use of protease inhibitors for the prevention of post-ERCP pancreatitis.
- Author
-
Baron TH and Itoi T
- Subjects
- Humans, Meta-Analysis as Topic, Pancreatitis etiology, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatitis prevention & control, Protease Inhibitors therapeutic use
- Published
- 2011
- Full Text
- View/download PDF
16. Mechanical pancreatitis secondary to parastomal herniation.
- Author
-
Aggarwal G, Baron TH, and Sweetser S
- Subjects
- Acute Disease, Aged, Cholangiopancreatography, Endoscopic Retrograde methods, Colectomy adverse effects, Colectomy methods, Crohn Disease diagnosis, Crohn Disease surgery, Duodenal Diseases diagnosis, Duodenal Diseases surgery, Female, Follow-Up Studies, Hernia, Ventral diagnosis, Humans, Ileostomy methods, Pancreatic Function Tests, Pancreatitis physiopathology, Pancreatitis surgery, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed methods, Treatment Outcome, Duodenal Diseases complications, Hernia, Ventral complications, Ileostomy adverse effects, Pancreatitis etiology
- Published
- 2011
- Full Text
- View/download PDF
17. Post-ERCP pancreatitis in pediatric patients.
- Author
-
Iqbal CW, Baron TH, Moir CR, and Ishitani MB
- Subjects
- Adolescent, Analysis of Variance, Child, Child, Preschool, Cholangiopancreatography, Endoscopic Retrograde classification, Humans, Pain etiology, Pancreatic Ducts surgery, Retrospective Studies, Risk Factors, Severity of Illness Index, Stents, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatitis etiology
- Abstract
Objectives: Pancreatitis is a known complication of endoscopic retrograde cholangiopancreatography (ERCP). Our aim was to assess the prevalence and severity of ERCP-associated pancreatitis using established criteria., Materials and Methods: Retrospective review of patients younger than 18 years undergoing ERCP complicated by post-ERCP pancreatitis defined by the 1991 consensus statement. Patients with chronic pancreatitis were studied separately using modified criteria. Risk factors for post-ERCP pancreatitis were analyzed., Results: Three hundred forty-three ERCPs were performed in 224 patients. Two hundred seventy-six ERCPs were performed in patients without chronic pancreatitis, 7 of which were complicated by post-ERCP pancreatitis (prevalence 2.5%). Patients undergoing diagnostic-only ERCP were less likely to develop post-ERCP pancreatitis (P<0.01). Sixty-seven procedures were performed on patients with chronic pancreatitis; 10 developed postprocedure pain requiring or prolonging hospitalization (prevalence 14.9%). Pancreatic duct stenting was a risk factor for post-ERCP pain in this subset of patients (P=0.02)., Conclusions: The prevalence of post-ERCP pancreatitis is low-2.5% excluding patients with chronic pancreatitis and 4.96% overall. Therapeutic procedures and the presence of chronic pancreatitis are risk factors for post-ERCP pancreatitis.
- Published
- 2009
- Full Text
- View/download PDF
18. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.
- Author
-
Chahal P, Tarnasky PR, Petersen BT, Topazian MD, Levy MJ, Gostout CJ, and Baron TH
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Treatment Failure, Treatment Outcome, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatic Ducts surgery, Pancreatitis prevention & control, Stents
- Abstract
Background & Aims: Prophylactic placement of pancreatic duct (PD) stents reduces the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) in high-risk patients. Some endoscopists prefer longer length, unflanged 3Fr PD stents because they are supposedly more effective and have a higher rate of spontaneous dislodgement; we compared outcomes of patients with these 2 types of stents., Methods: Patients at high risk for PEP were randomly assigned to groups given either a straight, 5Fr, 3 cm long, unflanged PD stent (n = 116) or a 3Fr, 8 cm or longer, unflanged PD stent (n = 133). Abdominal radiographs were obtained at 24 hours, 7 days, and 14 days following stent placement to assess spontaneous stent dislodgement. PEP was defined according to consensus criteria., Results: After 14 days, the spontaneous stent dislodgement rates were 98% for 5Fr stents and 88% for 3Fr stents (P = .0001). PEP occurred in 12% of patients. The incidence of PEP was higher in the 3Fr group (14%) than the 5Fr group (9%), although this difference was not statistically significant (P = .3). Placement failure did not occur in any patients in the 5Fr stent group, but did occur in 11 of the 133 patients in the 3Fr stent group (P = .0003)., Conclusions: Among patients at high-risk for PEP, the spontaneous dislodgement rate of unflanged, short-length, 5Fr PD stents is significantly higher than for unflanged, long-length, 3Fr stents. This decreases the need for endoscopic removal. A higher rate of PD stent placement failure and PEP was observed in patients with 3Fr stents. To view this article's video abstract, go to the AGA's YouTube Channel.
- Published
- 2009
- Full Text
- View/download PDF
19. Outcomes of intra-abdominal fungal vs. bacterial infections in severe acute pancreatitis.
- Author
-
Vege SS, Gardner TB, Chari ST, Baron TH, Clain JE, Pearson RK, Petersen BT, Farnell MB, and Sarr MG
- Subjects
- Acute Disease, Bacterial Infections drug therapy, Candidiasis drug therapy, Female, Humans, Male, Middle Aged, Severity of Illness Index, Treatment Outcome, Bacterial Infections epidemiology, Bacterial Infections etiology, Candidiasis epidemiology, Candidiasis etiology, Pancreatitis complications
- Abstract
Objectives: Intra-abdominal infection in severe acute pancreatitis (SAP) has significant morbidity and mortality; however, reports conflict on the outcome of patients with intra-abdominal fungal infection (IFI). We aimed to compare the morbidity and mortality of IFI compared with intra-abdominal bacterial infection (IBI) and no intra-abdominal infection (NII) in patients with SAP., Methods: Medical records of 207 consecutive patients admitted with SAP (per the Atlanta classification) to the Mayo Clinic (Rochester, Minnesota) between 1992 and 2001 were reviewed. All intra-abdominal microbiology cultures from pancreatic and peri-pancreatic necrosis, abscess, and/or pseudocyst obtained at operation, endoscopic necrosectomy or computed tomography-guided aspiration were reviewed. Patients were divided into three groups-IFI, IBI, and NII. Primary fungal infections were those for which there had been no prior abdominal interventions, and secondary infections were those that followed a prior intervention. Our main outcome was in-hospital mortality and secondary outcomes included the presence of organ failure (OF), need for surgical intervention, need for intensive care unit (ICU) care, and duration of hospitalization., Results: The groups were similar in terms of baseline characteristics, use of prophylactic antibiotics, use of enteral/parenteral nutrition, development of necrosis, and peripancreatic fluid collections. Fifty-two percent of patients had an intra-abdominal infection; all of these developed bacterial infections and 30 (15%) developed concomitant fungal infections. There were 7 primary fungal infections and 23 secondary infections-no important outcome differences were noted between these groups. Compared with patients with IBI, patients with IFI had longer hospital (63 vs. 37 days, P<0.01) and ICU (28 vs. 9 days, P<0.01) stays and higher rates of OF (73 vs. 47%, P<0.04), but similar mortality rates (20 vs. 17%, P0.41). Multivariate analysis revealed the presence of OF (odds ratio (OR) 2.4, 95% confidence interval (CI) 1,7) and the need for ICU care (OR 4.3, 95% CI 1,28) to be associated with IFI., Conclusions: Patients with SAP and IFI suffered greater in-hospital morbidity than did patients with IBI alone. Concomitant fungal infection, however, did not increase the in-hospital mortality rate.
- Published
- 2009
- Full Text
- View/download PDF
20. Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include "moderately severe acute pancreatitis".
- Author
-
Vege SS, Gardner TB, Chari ST, Munukuti P, Pearson RK, Clain JE, Petersen BT, Baron TH, Farnell MB, and Sarr MG
- Subjects
- Acute Disease, Female, Gastrointestinal Hemorrhage complications, Humans, Hypotension complications, Intensive Care Units, Male, Middle Aged, Pancreatitis complications, Pancreatitis mortality, Pancreatitis pathology, Pancreatitis, Acute Necrotizing classification, Pancreatitis, Acute Necrotizing complications, Pancreatitis, Acute Necrotizing mortality, Pancreatitis, Acute Necrotizing pathology, Renal Insufficiency complications, Respiratory Insufficiency complications, Pancreatitis classification
- Abstract
Objectives: Organ failure (OF) is a main cause of death in severe acute pancreatitis (SAP). Our primary aim was to evaluate the morbidity and mortality of patients admitted with SAP with no OF (NOF), single OF (SOF), and multiple (> or =2) OF (MOF)., Methods: Medical records of 207 consecutive patients admitted with SAP to the Mayo Clinic between 1992 and 2001 were reviewed. OF was defined according to the Atlanta classification and patients were categorized in the three groups-NOF, SOF, and MOF. Primary outcomes were in-hospital mortality, duration of hospitalization, need for the intensive care unit (ICU), and the mean length of stay in the ICU., Results: OF occurred in 108 patients (52%). Gastrointestinal bleeding occurred in 18%, respiratory failure in 36%, hypotension in 28%, and renal failure in 26%. Compared to patients with MOF, patients with NOF had shorter hospitalizations (28 vs. 55 days, P=0.02), less need for ICU care (50% vs. 90%, P=0.001), shorter time in the ICU (5 vs. 34 days, P<0.05), and decreased in-hospital mortality (2% vs. 46%, P<0.01). Odds ratios evaluating the risk of in-hospital mortality for subjects with any OF was 28 (7-186), 10 (2-69) for patients with SOF, and 64 (15-464) for patients with MOF., Conclusions: Patients with SAP and NOF have prolonged hospitalizations but low mortality. The Atlanta classification should be revised to include a patient group defined as "moderately severe acute pancreatitis" that identifies those patients currently classified as SAP without OF.
- Published
- 2009
- Full Text
- View/download PDF
21. A case of IgG4-associated cholangitis and autoimmune pancreatitis responsive to corticosteroids.
- Author
-
Small AJ, Loftus CG, Smyrk TC, and Baron TH
- Subjects
- Aged, Autoimmune Diseases, Cholangitis, Sclerosing drug therapy, Diagnosis, Differential, Glucocorticoids therapeutic use, Humans, Male, Pancreatitis drug therapy, Treatment Outcome, Cholangiocarcinoma diagnosis, Cholangitis, Sclerosing immunology, Immunoglobulin G immunology, Pancreatitis immunology
- Abstract
Background: A 72-year-old male presented to the emergency department with epigastric pain, anorexia and progressive jaundice of 1 week's duration. He had no prior history of gastrointestinal illness, diabetes or cancer. He did not smoke or consume alcohol. He did have a family history of colon and bone cancer., Investigations: Biochemical and serologic studies, CT scan, abdominal ultrasound, endoscopic ultrasound, endoscopic retrograde cholangiopancreatography, biliary cytology, pancreas needle biopsies and immunohistochemical stainings., Diagnosis: Autoimmune pancreatitis with IgG(4)-associated sclerosing cholangitis affecting the extrahepatic biliary ducts and mimicking primary sclerosing cholangitis and cholangiocarcinoma., Management: Corticosteroids and immunomodulatory therapy.
- Published
- 2008
- Full Text
- View/download PDF
22. CT findings of walled-off pancreatic necrosis (WOPN): differentiation from pseudocyst and prediction of outcome after endoscopic therapy.
- Author
-
Takahashi N, Papachristou GI, Schmit GD, Chahal P, LeRoy AJ, Sarr MG, Vege SS, Mandrekar JN, and Baron TH
- Subjects
- Adolescent, Adult, Aged, Child, Diagnosis, Differential, Female, Humans, Male, Prognosis, Reproducibility of Results, Sensitivity and Specificity, Treatment Outcome, Young Adult, Endoscopy methods, Pancreatic Pseudocyst diagnostic imaging, Pancreatic Pseudocyst surgery, Pancreatitis diagnostic imaging, Pancreatitis surgery, Tomography, X-Ray Computed methods
- Abstract
Computed tomography (CT) findings that may differentiate walled-off pancreatic necrosis (WOPN) from pancreatic pseudocyst were investigated. CT examinations performed before endoscopic therapy of pancreatic fluid collection (PFC) in 73 patients (45 WOPN, 28 pseudocysts) were evaluated retrospectively by two radiologists. PFC was evaluated for size, extension to paracolic space, characteristics of wall and internal structure. The pancreas was evaluated for deformity or discontinuity, and pancreatic duct dilation. CT findings that were associated with WOPN or pseudocyst were identified. CT score (number of CT findings associated with WOPN minus number of findings associated with pseudocyst) was calculated for each PFC. PFC was categorized as WOPN or pseudocyst using a CT score threshold. Larger size, extension to paracolic space, irregular wall definition, presence of fat attenuation debris in PFC, pancreatic deformity or discontinuity (P < 0.05-0.0001) were findings associated with WOPN. Presence of pancreatic duct dilation was associated with pseudocyst. Using a CT score of 2 or higher as a threshold, CT differentiated WOPN from pseudocyst with an accuracy of 79.5-83.6%. Thus, CT can differentiate WOPN from pseudocysts.
- Published
- 2008
- Full Text
- View/download PDF
23. Disconnected pancreatic duct syndrome in severe acute pancreatitis: clinical and imaging characteristics and outcomes in a cohort of 31 cases.
- Author
-
Pelaez-Luna M, Vege SS, Petersen BT, Chari ST, Clain JE, Levy MJ, Pearson RK, Topazian MD, Farnell MB, Kendrick ML, and Baron TH
- Subjects
- Acute Disease, Adult, Aged, Aged, 80 and over, Analysis of Variance, Cholangiopancreatography, Endoscopic Retrograde methods, Cohort Studies, Drainage methods, Endoscopy methods, Female, Follow-Up Studies, Humans, Laparotomy methods, Male, Middle Aged, Pancreatic Fistula etiology, Pancreatic Fistula surgery, Pancreatic Pseudocyst etiology, Pancreatic Pseudocyst pathology, Pancreatic Pseudocyst surgery, Pancreatitis mortality, Retrospective Studies, Risk Assessment, Severity of Illness Index, Survival Rate, Syndrome, Tomography, X-Ray Computed, Treatment Outcome, Diagnostic Imaging methods, Pancreatic Ducts abnormalities, Pancreatic Ducts surgery, Pancreatitis complications, Pancreatitis diagnosis
- Abstract
Background: Information regarding the natural history, clinical characteristics, and outcomes of disconnected pancreatic duct syndrome (DPDS) is limited., Objective: To describe clinical characteristics and outcomes of DPDS., Design: A retrospective review of the Mayo Clinic endoscopy and hospital service database., Setting: Tertiary-referral center., Patients: We identified 31 DPDS cases from 1999 to 2006., Interventions: Endoscopic drainage of pancreatic-fluid collections., Main Outcome Measurements: The relationship between demographic and clinical data with endoscopic treatment and clinical outcomes in DPDS cases., Results: The median patient age was 53 years (range 20-83 years); 48% were men. The most common etiology of acute pancreatitis (AP) was biliary (55%) followed by idiopathic (27%). The median interval between the diagnoses of AP and DPDS was 56 days (range 3-251 days); the median follow-up after the last ERCP or surgical procedure was 7 months (range 0-90 months). The DPDS location included the following: pancreas head 6%, neck 58%, body 26%, and tail 10%. Twenty-six patients had initial endoscopic treatment (19 had long-term improvement; 7 failed treatment and required surgery) and 5 underwent immediate surgery. Mortality was 0%; 26% developed chronic pancreatitis (CP) and 16% diabetes mellitus (DM); 10% resolved completely, 45% had smaller fluid collections, and 26% patients were lost to follow-up. No relationship between demographic and clinical data with endoscopic and clinical outcomes was found., Conclusions: Endoscopic treatment temporarily improved DPDS, with a failure rate of 23%. Immediate surgery was not required in all cases. CP and/or pancreatic atrophy occurred relatively shortly after the DPDS diagnosis in 26% and DM in 16% of cases. DPDS did not lead to mortality. Early surgery may be considered after initially stabilizing the fluid collection with endoscopic therapy.
- Published
- 2008
- Full Text
- View/download PDF
24. Drainage of pancreatic fluid collections: is EUS really necessary?
- Author
-
Baron TH
- Subjects
- Drainage methods, Endosonography instrumentation, Humans, Pancreatic Pseudocyst diagnosis, Pancreatitis diagnosis, Body Fluids metabolism, Endosonography methods, Pancreatic Pseudocyst complications, Pancreatitis complications
- Published
- 2007
- Full Text
- View/download PDF
25. Acute pancreatitis secondary to adenomatous transformation of the ampulla of Vater in a patient with familial adenomatous polyposis.
- Author
-
Batsis JA, Baron TH, and Arora AS
- Subjects
- Cholangiopancreatography, Endoscopic Retrograde, Common Bile Duct Diseases pathology, Electrocoagulation, Endoscopy, Gastrointestinal, Female, Humans, Middle Aged, Recurrence, Adenoma pathology, Adenomatous Polyposis Coli complications, Ampulla of Vater pathology, Common Bile Duct Diseases complications, Pancreatitis etiology
- Abstract
We present an unusual case of pancreatitis secondary to a polyp obstructing the papilla, treated endoscopically. A 45-year-old woman with familial adenomatous polyposis syndrome and prior total colectomy presented with acute pancreatitis. Upper endoscopy and endoscopic retrograde cholangiopancreaticogram revealed significant periampullary tissue. Sphincterotomy and endoscopic snare resection of the polyp were performed without complications. Local, noninvasive procedures are a promising diagnostic and therapeutic modality which has significantly less morbidity and mortality than conventional surgical techniques, and may be a reasonable alternative in the management of such patients.
- Published
- 2007
- Full Text
- View/download PDF
26. Endoscopic retrograde cholangiopancreatography-induced severe acute pancreatitis.
- Author
-
Vege SS, Chari ST, Petersen BT, Baron TH, Munukuti N, Bollineni S, and Rea JR
- Subjects
- Acute Disease, Demography, Female, Humans, Length of Stay, Male, Middle Aged, Pancreatitis pathology, Pancreatitis physiopathology, Retrospective Studies, Treatment Outcome, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatitis etiology, Postoperative Complications
- Abstract
Background/aims: There is scant information in the literature about the outcomes of endoscopic retrograde cholangiopancreatography (ERCP)-induced severe acute pancreatitis (ESAP). Compared to other causes, higher morbidity and mortality have been reported in ERCP-induced acute pancreatitis. We undertook this study to determine the differences between ESAP and SAP due to other causes (OSAP)., Methods: We retrospectively identified all cases of SAP admitted to our institution during the years 1992-2001. We reviewed the medical records of all SAP patients to obtain information on demographics, interventions, local and systemic complications and outcomes., Results: We identified 207 patients with SAP, of whom 16 (7.7%) had ESAP and 191 OSAP. There was no difference between ESAP and OSAP with regard to demographics, clinical interventions, local and systemic complications and outcomes. Both groups had a similar mortality (25 vs. 18%)., Conclusion: ESAP has a similar morbidity and mortality compared to OSAP., (Copyright 2006 S. Karger AG, Basel and IAP.)
- Published
- 2006
- Full Text
- View/download PDF
27. Biochemical analysis of pancreatic fluid collections predicts bacterial infection.
- Author
-
Mönkemüller KE, Harewood GC, Curioso WH, Fry LC, Wilcox CM, Morgan DE, and Baron TH
- Subjects
- Acute Disease, Adult, Biochemistry methods, Chronic Disease, Cohort Studies, Female, Humans, Male, Middle Aged, Multivariate Analysis, Pancreas pathology, Pancreatic Pseudocyst metabolism, Pancreatitis pathology, Predictive Value of Tests, Sensitivity and Specificity, Bacterial Infections diagnosis, Body Fluids chemistry, Body Fluids microbiology, Pancreas metabolism, Pancreatitis metabolism, Pancreatitis microbiology
- Abstract
Background and Aims: Despite our understanding of the pathophysiology of different types of pancreatic fluid collections (PFC), few studies have attempted to correlate the biochemical analysis of PFC contents with clinical and radiological characteristics. The aim of this study was to assess the predictive value of fluid analysis for discerning collection type (pseudocyst vs acute fluid collection with necrosis), presence of infection or communication with the pancreatic duct in the setting of acute and chronic pancreatitis., Methods: Pancreatic fluid from 34 consecutive patients undergoing endotherapy of PFC was prospectively analyzed for seven variables: lactate dehydrogenase (LDH), total protein, albumin, glucose, amylase, lipase and specific gravity., Results: In multivariate analysis, adjusting for age and gender, high intracystic levels of protein (OR 6.2; 95% CI 1.3-37.0), LDH (OR 6.8 [2.3-38.3]), and albumin (OR 7.8 [1.3-67.4]), and low levels of glucose (OR 0.2 [0.03-0.9]) predicted the presence of PFC infection. The optimal threshold value for protein was 1000 g/dL, which achieved a sensitivity of 73% and specificity of 75% for detecting infection; the optimal cut-off for LDH was 1000 U/L (sensitivity 64%, specificity 85%), and the cut-off for albumin was 500 g/dL (sensitivity 75%, specificity 85%). There were no statistically significant differences in biochemical fluid analysis with respect to fluid collection type (pseudocysts vs acute fluid collection with necrosis) and the presence of pancreatic duct communication., Conclusions: Biochemical analysis of PFC fluid is clinically helpful in detecting fluid infection in patients with bacteria on Gram stain or positive fluid cultures. Our findings fail to support the utility of fluid analysis in characterizing cyst type, and we caution against its use in distinguishing pseudocysts from acute fluid collection with necrosis.
- Published
- 2005
- Full Text
- View/download PDF
28. Endotherapy for complications of pancreatitis: ready for prime time.
- Author
-
Baron TH
- Subjects
- Humans, Endoscopy, Gastrointestinal methods, Pancreatitis complications, Pancreatitis surgery
- Published
- 2004
- Full Text
- View/download PDF
29. Endoscopic therapy with multiple plastic stents for benign biliary strictures due to chronic calcific pancreatitis: the good, the bad, and the ugly.
- Author
-
Baron TH
- Subjects
- Biliary Tract Diseases etiology, Calcinosis complications, Chronic Disease, Constriction, Pathologic surgery, Humans, Plastics, Biliary Tract Diseases surgery, Endoscopy, Digestive System, Pancreatitis complications, Stents
- Published
- 2004
- Full Text
- View/download PDF
30. Complications of ERCP.
- Author
-
Mallery JS, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Leighton JA, Raddawi HM, Varg JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J, Eisen GM, and Faigel DO
- Subjects
- Antibiotic Prophylaxis, Catheterization, Cholangiopancreatography, Endoscopic Retrograde methods, Hemorrhage etiology, Humans, Pancreatitis prevention & control, Patient Selection, Sphincterotomy, Endoscopic adverse effects, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Pancreatitis etiology
- Published
- 2003
- Full Text
- View/download PDF
31. Past, present, and future of endoscopic retrograde cholangiopancreatography: perspectives on the National Institutes of Health consensus conference.
- Author
-
Baron TH and Fleischer DE
- Subjects
- Abdominal Pain diagnosis, Ampulla of Vater pathology, Bile Duct Neoplasms pathology, Cholelithiasis surgery, Consensus Development Conferences, NIH as Topic, Contraindications, Humans, Pancreatic Neoplasms pathology, United States, Bile Duct Neoplasms diagnosis, Cholangiopancreatography, Endoscopic Retrograde adverse effects, Cholangiopancreatography, Endoscopic Retrograde trends, Cholelithiasis diagnosis, Pancreatic Neoplasms diagnosis, Pancreatitis therapy
- Published
- 2002
- Full Text
- View/download PDF
32. Groove pancreatitis: From enigma to future directions—A comprehensive review.
- Author
-
Dahiya, Dushyant S., Shah, Yash R., Canakis, Andrew, Parikh, Charmy, Chandan, Saurabh, Ali, Hassam, Gangwani, Manesh K., Pinnam, Bhanu S. M., Singh, Sahib, Sohail, Amir H., Patel, Raj, Ramai, Daryl, Al‐Haddad, Mohammad, Baron, Todd, and Rastogi, Amit
- Abstract
Groove pancreatitis (GP) is a rare and clinically distinct form of chronic pancreatitis affecting the pancreaticoduodenal groove comprising the head of the pancreas, duodenum, and the common bile duct. It is more prevalent in individuals in their 4–5th decade of life and disproportionately affects men compared with women. Excessive alcohol consumption, tobacco smoking, pancreatic ductal stones, pancreatic divisum, annular pancreas, ectopic pancreas, duodenal wall thickening, and peptic ulcers are significant risk factors implicated in the development of GP. The usual presenting symptoms include severe abdominal pain, nausea, vomiting, diarrhea, weight loss, and jaundice. Establishing a diagnosis of GP is often challenging due to significant clinical and radiological overlap with numerous benign and malignant conditions affecting the same anatomical location. This can lead to a delay in initiation of treatment leading to increasing morbidity, mortality, and complication rates. Promising research in artificial intelligence (AI) has garnered immense interest in recent years. Due to its widespread application in diagnostic imaging with a high degree of sensitivity and specificity, AI has the potential of becoming a vital tool in differentiating GP from pancreatic malignancies, thereby preventing a missed or delayed diagnosis. In this article, we provide a comprehensive review of GP, covering the etiology, pathogenesis, clinical presentation, radiological and endoscopic evaluation, management strategies, and future directions. This article also aims to increase awareness about this lesser known and often‐misdiagnosed clinical entity amongst clinicians to ultimately improve patient outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Hydrogen Peroxide-Assisted Endoscopic Necrosectomy for Walled-Off Pancreatic Necrosis: A Dual Center Pilot Experience
- Author
-
Siddiqui, Ali A., Easler, Jeffrey, Strongin, Anna, Slivka, Adam, Kowalski, Thomas E., Muddana, Venkata, Chennat, Jennifer, Baron, Todd H., Loren, David E., and Papachristou, Georgios I.
- Published
- 2014
- Full Text
- View/download PDF
34. Endoscopic Biliary Sphincterotomy Is Not Required for Transpapillary SEMS Placement for Biliary Obstruction
- Author
-
Banerjee, Nikhil, Hilden, Kristen, Baron, Todd H., and Adler, Douglas G.
- Published
- 2011
- Full Text
- View/download PDF
35. Stenotrophomonas (Xanthomonas) maltophilia infection in necrotizing pancreatitis
- Author
-
Mönkemüller, Klaus E., Morgan, Desiree E., and Baron, Todd H.
- Published
- 1999
- Full Text
- View/download PDF
36. Endoscopic management of pancreatic pseudocysts and necrosis.
- Author
-
Law, Ryan and Baron, Todd H
- Subjects
NECROSIS ,PANCREATITIS ,INFLAMMATION ,PANCREATIC diseases ,THERAPEUTICS - Abstract
Over the last several years, there have been refinements in the understanding and nomenclature regarding the natural history of acute pancreatitis. Patients with acute pancreatitis frequently develop acute pancreatic collections that, over time, may evolve into pancreatic pseudocysts or walled-off necrosis. Endoscopic management of these local complications of acute pancreatitis continues to evolve. Treatment strategies range from simple drainage of liquefied contents to repeated direct endoscopic necrosectomy of a complex necrotic collection. In patients with chronic pancreatitis, pancreatic pseudocysts may arise as a consequence of pancreatic ductal obstruction that then leads to pancreatic ductal disruption. In this review, we focus on the indications, techniques and outcomes for endoscopic therapy of pancreatic pseudocysts and walled-off necrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
37. Endoscopic Treatment of Benign Biliary Strictures Using Covered Self-Expandable Metal Stents (CSEMS).
- Author
-
Irani, Shayan, Baron, Todd, Akbar, Ali, Lin, Otto, Gluck, Michael, Gan, Ian, Ross, Andrew, Petersen, Bret, Topazian, Mark, and Kozarek, Richard
- Subjects
- *
ENDOSCOPY , *BILE duct abnormalities , *SURGICAL stents , *TERTIARY care , *PANCREATITIS , *METALS in surgery , *RETROSPECTIVE studies - Abstract
Background and Aims: Traditional endoscopic management of benign biliary strictures (BBS) consists of placement of one or more plastic stents. Emerging data support the use of covered self-expandable metal stents (CSEMS). We sought to assess outcome of endoscopic temporary placement of CSEMS in patients with BBS. Methods: This was a retrospective study of CSEMS placement for BBS between May 2005 and July 2012 from two tertiary care centers. A total of 145 patients (81 males, median age 59 years) with BBS were identified; 73 of which were classified as extrinsic and were caused by chronic pancreatitis, and 70 were intrinsic. Main outcome measures were resolution of stricture and adverse events (AEs) due to self-expandable metal stents (SEMS)-related therapy. Results: Fully covered and partially covered 8-10 mm diameter SEMS were placed and subsequently removed in 121/125 (97 %) attempts in BBS (failure to remove four partially covered stents). Stricture resolution occurred in 83/125 (66 %) patients after a median stent duration of 26 weeks (median follow-up 90 weeks). Resolution of extrinsic strictures was significantly lower compared to intrinsic strictures (31/65, 48 % vs. 52/60, 87 %, p = 0.004) despite longer median stent duration (30 vs. 20 weeks). Thirty-seven AEs occurred in 25 patients (17 %), with 12 developing multiple AEs including cholangitis ( n = 17), pancreatitis ( n = 5), proximal stent migration ( n = 3), cholecystitis ( n = 2), pain requiring SEMS removal and/or hospitalization ( n = 3), inability to remove ( n = 4), and new stricture formation ( n = 3). Conclusions: Benign biliary strictures can be effectively treated with CSEMS. Successful resolution of biliary strictures due to extrinsic disease is seen significantly less often than those due to intrinsic disease. Removal is successful in all patients with fully covered SEMS. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
38. Acute biliary conditions.
- Author
-
de C. Ferreira, Lincoln E. V. V. and Baron, Todd H.
- Subjects
GALLSTONES ,PANCREATITIS ,CHOLECYSTITIS ,LIVER abscesses ,NECROTIZING pancreatitis ,CHOLECYSTECTOMY - Abstract
Acute biliary complications may result from several medical conditions such as gallstone pancreatitis, acute cholangitis, acute cholecystitis, bile leak, liver abscess and hepatic trauma. Gallstones are the most common cause of acute pancreatitis. About 25% of theses patients will develop clinically severe acute pancreatitis, usually due to necrotizing pancreatitis. Choledocholithiasis, malignant and benign biliary strictures, and stent dysfunction may cause partial or complete obstruction and infection in the biliary tract with acute cholangitis. Bile leaks are most commonly associated with hepatobiliary surgeries or invasive procedures such as open or laparoscopic cholecystectomy, hepatic resection, hepatic transplantation, liver biopsy, and percutaneous transhepatic cholangiography. Endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) may have an essential role in the management of these complications. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
39. ERCP.
- Author
-
Law, Ryan and Baron, Todd H.
- Subjects
- *
ENDOSCOPIC retrograde cholangiopancreatography , *PANCREATITIS , *ENDOSCOPY , *NONSTEROIDAL anti-inflammatory agents , *PANCREATIC duct , *CHOLANGIOSCOPY , *SURGICAL stents - Abstract
Technological advances in ERCP have appeared to plateau. Nonetheless, specific areas within ERCP were well represented at this year's Digestive Disease Week (DDW). These areas are subdivided and discussed in detail. As expected, there remains concern about prevention of post-ERCP pancreatitis (PEP). Although pharmacologic therapy by using nonsteroidal anti-inflammatory drugs (NSAIDs) has clearly emerged as an alternative and/or adjunct to pancreatic duct (PD) stents, stents seem to remain the mainstay in the endoscopists' armamentarium for the prevention of PEP. Other topics covered included the use of cholangioscopy, diagnosis of biliary strictures, and treatment of strictures by using stents and radiofrequency ablation. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
40. Endotherapy for Organized Pancreatic Necrosis: Perspectives After 20 Years.
- Author
-
Baron, Todd H. and Kozarek, Richard A.
- Subjects
ENDOSCOPY ,PANCREATITIS ,NECROSIS ,BIOLOGICAL nomenclature ,ORAL drug administration ,TOMOGRAPHY ,PATIENTS - Abstract
It has been nearly 20 years since the first peroral endoscopic necrosectomy was performed for patients with pancreatitis. We have since increased our understanding of pancreatitis, and the nomenclature has changed to define disease in which necrosis becomes organized (called “walled-off”). Endoscopic approaches to evaluate and treat pancreatitis have progressed from making small transmural tracts for irrigation to making large tracts, which allow the endoscope to move directly into necrotic cavities and perform endoscopic necrosectomy. The purpose of endoscopic debridement is to irrigate and/or remove areas of necrosis. Collaboration between therapeutic endoscopists and interventional radiologists has led to a combined approach to organized pancreatic necrosis. We discuss the history of peroral endoscopic treatment of organized (walled-off) pancreatic necrosis and current endoscopic approaches to therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
41. Endoscopic drainage of pancreatic pseudocysts.
- Author
-
Baron, Todd H.
- Subjects
- *
PANCREATIC cysts , *SURGICAL drainage , *ENDOSCOPIC surgery , *PANCREATITIS , *PANCREATIC fistula , *DISEASE relapse , *DIGESTIVE system endoscopic surgery , *MEDICAL drainage ,DIGESTIVE organ surgery - Abstract
Pancreatic pseudocysts arise as a complication of acute and chronic pancreatitis, pancreatic trauma, or after surgery. Endoscopic treatment of pancreatic pseudocysts can be achieved using transpapillary and/or transmural (transgastric or transduodenal) approaches with acceptable success rates, complication rates, and recurrence rates. Advantages of endoscopic drainage is the avoidance of external pancreatic fistula. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
42. Quality Indicators for Endoscopic Ultrasonography.
- Author
-
Jacobson, Brian C., Chak, Amitabh, Hoffman, Brenda, Baron, Todd H., Cohen, Jonathan, Deal, Stephen E., Mergener, Klaus, Petersen, Bret T., Petrini, John L., Safdi, Michael A., Faigel, Douglas O., and Pike, Irving M.
- Subjects
ENDOSCOPIC ultrasonography ,DIAGNOSTIC ultrasonic imaging ,DIAGNOSTIC imaging ,PANCREATITIS ,PANCREATIC diseases - Abstract
The article provides information about the quality indicators that are particular to endoscopic ultrasonography (EUS). Preprocedural indicators include the proper indications that are provided before performance of EUS. Intraprocedural indicator include the documentation of the appearance of relevant structures specific for EUS indication. Postprocedural indicator include the measurement of the incidence of pancreatitis after EUS-guided fine-needle aspiration of the pancreas.
- Published
- 2006
- Full Text
- View/download PDF
43. A Randomized Trial of Endoscopic Biliary Sphincterotomy Using Pure-Cut Versus Combined Cut and Coagulation Waveforms.
- Author
-
Norton, Ian D., Petersen, Bret T., Bosco, Jay, Nelson, Doug B., Meier, Peter B., Baron, Todd H., Lange, Stephen M., Gostout, Christopher J., Loeb, David S., Levy, Michael J., Wiersema, Maurits J., and Pochron, Nicole
- Subjects
PANCREATITIS ,HEMORRHAGE ,BLOOD coagulation ,PATIENTS - Abstract
Background & Aims: Endoscopic biliary sphincterotomy has complication rates of 5%–12%. The output from the electrosurgical generator may influence the degree of coagulation and the rapidity of the incision, and thus rates of pancreatitis, hemorrhage, and perforation. Some modern generators incorporate feedback control to standardize output and automate the alternating cut and coagulation modes. Our aim was to compare 2 feedback-controlled generators, one with constant pure cutting–type output and the other with an alternating cut and coagulation mode. Methods: In this multicenter randomized study, 133 patients were assigned to the alternating cut/coag output and 134 patients were assigned to constant pure-cut output. Patients were stratified by their risk for pancreatitis. Results: The overall pancreatitis rate was 1.5%, including 3 patients in the cut/coag group and 1 patient in the pure-cut group (P > .05). There were 11 poorly controlled (zipper) incisions in the pure-cut group and none in the cut/coag group (P = .02). The incision was completed in all patients without stalling. Immediate hemorrhage occurred in 35 pure-cut patients and 8 cut/coag patients output (P = .002). There were no episodes of clinically significant bleeding, delayed bleeding, or perforation. Conclusions: Biliary sphincterotomy using feedback-controlled generators results in dependable progression of incision with a low pancreatitis rate. Control of the incision is improved subjectively with the cut/coagulation output, but this did not translate into a difference in clinically significant complications. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
44. The diagnosis and management of fluid collections associated with pancreatitis.
- Author
-
Baron, Todd H. and Morgan, Desiree E.
- Subjects
- *
PANCREATITIS - Abstract
Examines pancreatitis and its complications, especially in pancreatic collections. Details on pancreatitis; Comparison of mild acute and severe acute pancreatitis; Information on the management of pancreatitis.
- Published
- 1997
- Full Text
- View/download PDF
45. Preoperative Biliary Stents in Pancreatic Cancer — Proceed with Caution.
- Author
-
Baron, Todd H. and Kozarek, Richard A.
- Subjects
- *
SURGICAL stents , *PANCREATIC cancer , *ENDOSCOPIC retrograde cholangiopancreatography , *PANCREATITIS , *HEMORRHAGE - Abstract
In this article, the authors comment on a study by N. A. van der Gaag on the preoperative biliary stents of patients with pancreatic cancer. Findings include an initial endoscopic retrograde cholangiopancreatography (ERCP) procedural failure rate of 25 percent and (ERCP)-related complications of pancreatitis, perforation, bleeding and cholangitis. The authors believe that self-expandable metallic stents (SEMS) might have precluded some of the problems designed in the trial.
- Published
- 2010
- Full Text
- View/download PDF
46. American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis.
- Author
-
Baron, Todd H., DiMaio, Christopher J., Wang, Andrew Y., and Morgan, Katherine A.
- Abstract
The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update is to review the available evidence and expert recommendations regarding the clinical care of patients with pancreatic necrosis and to offer concise best practice advice for the optimal management of patients with this highly morbid condition. This expert review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. This review is framed around the 15 best practice advice points agreed upon by the authors, which reflect landmark and recent published articles in this field. This expert review also reflects the experiences of the authors, who are advanced endoscopists or hepatopancreatobiliary surgeons with extensive experience in managing and teaching others to care for patients with pancreatic necrosis. Pancreatic necrosis is associated with substantial morbidity and mortality and optimal management requires a multidisciplinary approach, including gastroenterologists, surgeons, interventional radiologists, and specialists in critical care medicine, infectious disease, and nutrition. In situations where clinical expertise may be limited, consideration should be given to transferring patients with significant pancreatic necrosis to an appropriate tertiary-care center. Antimicrobial therapy is best indicated for culture-proven infection in pancreatic necrosis or when infection is strongly suspected (ie, gas in the collection, bacteremia, sepsis, or clinical deterioration). Routine use of prophylactic antibiotics to prevent infection of sterile necrosis is not recommended. When infected necrosis is suspected, broad-spectrum intravenous antibiotics with ability to penetrate pancreatic necrosis should be favored (eg, carbapenems, quinolones, and metronidazole). Routine use of antifungal agents is not recommended. Computed tomography–guided fine-needle aspiration for Gram stain and cultures is unnecessary in the majority of cases. In patients with pancreatic necrosis, enteral feeding should be initiated early to decrease the risk of infected necrosis. A trial of oral nutrition is recommended immediately in patients in whom there is absence of nausea and vomiting and no signs of severe ileus or gastrointestinal luminal obstruction. When oral nutrition is not feasible, enteral nutrition by either nasogastric/duodenal or nasojejunal tube should be initiated as soon as possible. Total parenteral nutrition should be considered only in cases where oral or enteral feeds are not feasible or tolerated. Drainage and/or debridement of pancreatic necrosis is indicated in patients with infected necrosis. Drainage and/or debridement may be required in patients with sterile pancreatic necrosis and persistent unwellness marked by abdominal pain, nausea, vomiting, and nutritional failure or with associated complications, including gastrointestinal luminal obstruction; biliary obstruction; recurrent acute pancreatitis; fistulas; or persistent systemic inflammatory response syndrome. Pancreatic debridement should be avoided in the early, acute period (first 2 weeks), as it has been associated with increased morbidity and mortality. Debridement should be optimally delayed for 4 weeks and performed earlier only when there is an organized collection and a strong indication. Percutaneous drainage and transmural endoscopic drainage are both appropriate first-line, nonsurgical approaches in managing patients with walled-off pancreatic necrosis (WON). Endoscopic therapy through transmural drainage of WON may be preferred, as it avoids the risk of forming a pancreatocutaneous fistula. Percutaneous drainage of pancreatic necrosis should be considered in patients with infected or symptomatic necrotic collections in the early, acute period (<2 weeks), and in those with WON who are too ill to undergo endoscopic or surgical intervention. Percutaneous drainage should be strongly considered as an adjunct to endoscopic drainage for WON with deep extension into the paracolic gutters and pelvis or for salvage therapy after endoscopic or surgical debridement with residual necrosis burden. Self-expanding metal stents in the form of lumen-apposing metal stents appear to be superior to plastic stents for endoscopic transmural drainage of necrosis. The use of direct endoscopic necrosectomy should be reserved for those patients with limited necrosis who do not adequately respond to endoscopic transmural drainage using large-bore, self-expanding metal stents/lumen-apposing metal stents alone or plastic stents combined with irrigation. Direct endoscopic necrosectomy is a therapeutic option in patients with large amounts of infected necrosis, but should be performed at referral centers with the necessary endoscopic expertise and interventional radiology and surgical backup. Minimally invasive operative approaches to the debridement of acute necrotizing pancreatitis are preferred to open surgical necrosectomy when possible, given lower morbidity. Multiple minimally invasive surgical techniques are feasible and effective, including videoscopic-assisted retroperitoneal debridement, laparoscopic transgastric debridement, and open transgastric debridement. Selection of approach is best determined by pattern of disease, physiology of the patient, experience and expertise of the multidisciplinary team, and available resources. Open operative debridement maintains a role in the modern management of acute necrotizing pancreatitis in cases not amenable to less invasive endoscopic and/or surgical procedures. For patients with disconnected left pancreatic remnant after acute necrotizing mid-body necrosis, definitive surgical management with distal pancreatectomy should be undertaken in patients with reasonable operative candidacy. Insufficient evidence exists to support the management of the disconnected left pancreatic remnant with long-term transenteric endoscopic stenting. A step-up approach consisting of percutaneous drainage or endoscopic transmural drainage using either plastic stents and irrigation or self-expanding metal stents/lumen-apposing metal stents alone, followed by direct endoscopic necrosectomy, and then surgical debridement is reasonable, although approaches may vary based on the available clinical expertise. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
47. Managing Risks Related to ERCP in Elderly Patients with Difficult Bile Duct Stones.
- Author
-
Meine, Gilmara and Baron, Todd
- Subjects
- *
GALLSTONE treatment , *OLDER patients , *ENDOSCOPIC retrograde cholangiopancreatography , *NONINVASIVE diagnostic tests , *DIVERTICULOSIS , *PANCREATITIS - Published
- 2014
- Full Text
- View/download PDF
48. Predicting the Severity of Acute Pancreatitis: Is It Time to Concentrate on the Hematocrit?
- Author
-
Baron, Todd H.
- Subjects
NECROTIZING pancreatitis ,PANCREATITIS ,PANCREATIC diseases ,NECROSIS ,PATIENTS - Abstract
Focuses on a study that evaluates hemoconcentration upon hospital admission as a potential marker of clinically severe and necrotizing pancreatitis. Background on studies about hemoconcentration; Usefulness of hemoconcentration as a potential marker for severe pancreatitis; Absence of hemoconcentration in patients.
- Published
- 2001
- Full Text
- View/download PDF
49. Endoscopic Retrograde Cholangiography Does Not Reliably Distinguish IgG4-Associated Cholangitis From Primary Sclerosing Cholangitis or Cholangiocarcinoma.
- Author
-
Kalaitzakis, Evangelos, Levy, Michael, Kamisawa, Terumi, Johnson, Gavin J., Baron, Todd H., Topazian, Mark D., Takahashi, Naoki, Kanno, Atsushi, Okazaki, Kazuichi, Egawa, Naoto, Uchida, Kazushige, Sheikh, Kashif, Amin, Zahir, Shimosegawa, Tooru, Sandanayake, Neomal S., Church, Nicholas I., Chapman, Michael H., Pereira, Stephen P., Chari, Suresh, and Webster, George J.M.
- Subjects
ENDOSCOPIC retrograde cholangiopancreatography ,BILIOUS diseases & biliousness ,CHOLANGIOGRAPHY ,CHOLANGIOCARCINOMA ,IMMUNOGLOBULIN G ,PANCREATITIS ,STEROID drugs ,ENDOSCOPY ,MEDICAL imaging systems - Abstract
Background & Aims: Distinction of immunoglobulin G4–associated cholangitis (IAC) from primary sclerosing cholangitis (PSC) or cholangiocarcinoma is challenging. We aimed to assess the performance characteristics of endoscopic retrograde cholangiography (ERC) for the diagnosis of IAC. Methods: Seventeen physicians from centers in the United States, Japan, and the United Kingdom, unaware of clinical data, reviewed 40 preselected ERCs of patients with IAC (n = 20), PSC (n = 10), and cholangiocarcinoma (n = 10). The performance characteristics of ERC for IAC diagnosis as well as the κ statistic for intraobserver and interobserver agreement were calculated. Results: The overall specificity, sensitivity, and interobserver agreement for the diagnosis of IAC were 88%, 45%, and 0.18, respectively. Reviewer origin, specialty, or years of experience had no statistically significant effect on reporting success. The overall intraobserver agreement was fair (0.74). The operating characteristics of different ERC features for the diagnosis of IAC were poor. Conclusions: Despite high specificity of ERC for diagnosing IAC, sensitivity is poor, suggesting that many patients with IAC may be misdiagnosed with PSC or cholangiocarcinoma. Additional diagnostic strategies are likely to be vital in distinguishing these diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.